Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
10.2M
-
Shares change
-
-8.08K
-
Total reported value, excl. options
-
$412M
-
Value change
-
+$3.08M
-
Put/Call ratio
-
0.77
-
Number of buys
-
67
-
Number of sells
-
-46
-
Price
-
$40.23
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q4 2022
144 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q4 2022.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.2M shares
of 22.3M outstanding shares and own 46.01% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.98M shares), VANGUARD GROUP INC (813K shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (527K shares), DIMENSIONAL FUND ADVISORS LP (527K shares), Global Alpha Capital Management Ltd. (450K shares), STATE STREET CORP (448K shares), EMERALD ADVISERS, LLC (443K shares), THOMPSON SIEGEL & WALMSLEY LLC (415K shares), Rubric Capital Management LP (376K shares), and FIRST WILSHIRE SECURITIES MANAGEMENT INC (361K shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.